Showing 1041-1050 of 1197 results for "".
- Revance Announces CEO Transitionhttps://modernaesthetics.com/news/revance-announces-ceo-transition/2475370/Revance announced a leadership transition last week as part of a long-term succession strategy following its integration with Crown Laboratories, according to a news release from the company.
- Skin Clique Expands Virtual Services with Nationwide Esthetician Programhttps://modernaesthetics.com/news/skin-clique-expands-virtual-services-with-nationwide-esthetician-program/2475363/Skin Clique, a physician-founded aesthetic care provider, has launched a virtual Esthetician Program to expand access to individualized skin
- iS Clinical Executives Explain Impact of New Peel Systemhttps://modernaesthetics.com/news/is-clinical-executives-explain-impact-of-new-peel-system/2475354/The next evolution of iS Clinical’s Active Peel System is the iS Clinical Extra Strength Active Peel Brightening System, which launched this week exclusively through authorized iS Clinical professionals nationwide, the company announced. The system’s professional-grade results include
- Registration Opens for the Tell-All Tribune and Genesis Meetingshttps://modernaesthetics.com/news/register-now-for-the-tell-all-tribune-and-genesis-meetings/2473764/Registration is open for two Modern Aesthetics meetings that were overwhelmingly popular in 2024 and now will be held on the same weekend, June 20-21, at the W Hotel in Fort Lauderdale, Florida.
- FDA Approves South Korean Neurotoxin for Frown Lineshttps://modernaesthetics.com/news/fda-approves-south-korean-neurotoxin-for-frown-lines/2473751/The US Food and Drug Administration approved the neurotoxin, Letybo (letibotulinumtoxinA-wlbg), to treat moderate-to-severe glabellar lines in adults, Hugel Inc. announced last week. According to a press release, Hugel Inc. plans to accelerate its transition for approved medical u
- Merz Aesthetics Releases Findings of Inaugural Global Study Connecting Aesthetics and Self-Affirmationhttps://modernaesthetics.com/news/merz-aesthetics-releases-findings-of-inaugural-global-study-connecting-aesthetics-and-self-affirmation/2473732/Merz Aesthetics launched its inaugural global study in Paris on Wednesday ahead of IMCAS World Congress. The Pillars of Confidence: Global Insights on Aesthetics and Self-Affirmation study, with research support from Ipsos, explores the role confidence plays in daily life and overa
- Allergan Aesthetics Unveiling New AA Signature Program, Immersive Booth at IMCAS World Congress 2025https://modernaesthetics.com/news/allergan-aesthetics-unveiling-new-aa-signature-program-immersive-booth-at-imcas-world-congress-2025/2473731/Allergan Aesthetics, an AbbVie company, is elevating the patient journey with the launch of its news AA Signature Program at the International Master Course of Aging Science (IMCAS) World Congress 2025 in Paris from January 31 through February 1. The new AA Signature Program will
- Legal Expert Discusses Industry Outlook for 2025https://modernaesthetics.com/news/legal-expert-discusses-industry-outlook-for-2025/2473729/As a partner in the law firm Michelman & Robinson's Commercial & Business Litigation Practice, Madison Dini has a well-informed perspective on the medical industry. Among other trends, Dini expects an uptick in mergers and acquisitions (M&A) activity within medtech and aesthetics
- Free Online Business Training Service Added to Allergan Medical Institutehttps://modernaesthetics.com/news/free-online-business-training-service-added-to-allergan-medical-institute/2473715/Allergan Aesthetics launched a new, free training service to Allergan Medical Institute to provide support to growing practices in the rapidly growing aesthetic medical spa market. The latest courses added to the online platform are the first business education courses, previously it was only cli
- First US Women Successfully Received Breast Augmentation with Newly Approved Motiva Implantshttps://modernaesthetics.com/news/first-us-women-successfully-received-breast-augmentation-with-newly-approved-motiva-implants/2473712/The first patients in the United States successfully received breast augmentations with Motive Implants, a week after receiving approval from the US Food and Drug Administration, Establishment Labs Holding Inc. announced in a press release last month. “With the FDA approval